Gilead Sciences (GILD) Short-term Investments (2009 - 2026)

Gilead Sciences (GILD) has reported Short-term Investments for 17 consecutive years, with $15.0 million the latest figure, recorded in Q1 2026.

• Short-term Investments for Q1 2026 came in at $15.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $15.0 million (changed N/A YoY), and the FY2025 annual result was $68.0 million, changed N/A from the prior year.
• Short-term Investments was $15.0 million for Q1 2026 at Gilead Sciences, down from $68.0 million in the prior quarter.
• Over five years, Short-term Investments peaked at $1.2 billion in Q4 2023 and troughed at $15.0 million in Q1 2026.
• Average Short-term Investments over 4 years is $691.2 million, with a median of $948.5 million recorded in 2022.
• Year-over-year, Short-term Investments slumped 43.38% in 2022 and climbed 21.17% in 2023.
• Over 4 years, Short-term Investments stood at $973.0 million in 2022, then grew by 21.17% to $1.2 billion in 2023, then sank by 94.23% to $68.0 million in 2025, then sank by 77.94% to $15.0 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $15.0 million in Q1 2026, $68.0 million in Q4 2025, and $19.0 million in Q3 2025.